Related Experiment Video
Updated: Jul 15, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin
Muhammad Riaz1, Bruce D Ragsdale2, Zia Ur Rahman3
1Sleep Medicine, Sunnyside Community Hospital and Clinics, 1016 Tacoma Avenue, Sunnyside, Washington 98944.
Abstract:
Drug rash with eosinophilia and systemic symptoms (DRESS) is a rare but potentially life-threatening condition with high mortality. Diagnosis is challenging due to variable clinical presentation and a protracted latency period following initiation of the offending drug. DRESS is a complex interplay that starts by introduction of the offending drug, reactivation of viruses and activation of the immune system. Herpes virus reactivation is considered a diagnostic marker and indicator of illness severity. Prompt recognition and the removal of offending agent remain the key to successful treatment. In cases of severe organ involvement, corticosteroids, immunoglobulins, antiviral and specialist consultation may be helpful. Here we present a case of a 36-year-old African-American male who presented with symptoms mimicking sepsis with an associated skin eruption that was diagnosed as DRESS.
Related Concept Videos
Allergic Reactions
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Drug toxicity: Idiosyncratic Reactions
Toxidromes: Clinical Features

